Multiple Sclerosis Discovery Forum

Inspiring Connections

Utility Navigation

User Top Menu

Home

Welcome to the Multiple Sclerosis Discovery Forum

An online community and information portal that aims to inspire connections and clinical advances
 

 

 

Become a Member

News & Future Directions

News Briefs | 24 Jul 2014

MS Patients Positive for Oligoclonal Bands Have Greater Brain Atrophy

A new global brain MRI study shows that patients who test positive for oligoclonal bands have greater loss of white matter than MS patients lacking those bands. The results of the study suggest that there may be reason to consider MS patients without oligoclonal bands to be a clinically distinct subgroup.

Patients lacking oligoclonal bands have less overall brain atrophy than those who...
News Synthesis | 22 Jul 2014

MS Family Planning 101: Should DMTs Be Discontinued Before and During Pregnancy?

The recent availability of a variety of disease-modifying therapies for RRMS raises many questions about when and which DMTs patients should start or stop before and during pregnancy

Like many autoimmune diseases, multiple sclerosis affects twice as many women as men. The average patient...
New Findings | 21 Jul 2014

EDSS Alternative in an iPad

A study demonstrates that an iPad app can accurately gauge walking, balance, manual dexterity, visual acuity, and a measure of cognition in people with MS

Doctors, researchers, and patients could all benefit from an easier way to quantify...

Research Resources

Tools that will help investigators conceive and perform experimental work:

  • The Data Visualization section presents MS-related data in new ways, making it easy for viewers to discover unexpected relationships
    Our latest visualization is based on the study Natural History of Multiple Sclerosis Symptoms, which appeared in the Fall 2013 issue of the International Journal of MS Care. It shows how the symptoms of multiple sclerosis change over the course of a lifetime. As we explained in the article we published in November 2013, Ilya Kister, M.D., of the NYU Multiple Sclerosis Care Center, Department of Neurology, NYU School of Medicine, New York, NY, and colleagues used data from 25,728 patients in the NARCOMS Registry to develop a series of symptom severity charts in 11 domains commonly affected in MS.

  • Drug-Development Pipeline consolidates key information about compounds under investigation for therapeutic use
    We've added three new trials, updated information on two trials, and added 16 other pieces of information. The drugs with important additions and changes are dimethyl fumarate, fingolimod, glatiramer acetate, interferon β-1a, interferon β-1b, minocycline, and natalizumab.
  • Tissue Repositories lists features of the world's tissue repositories and brain banks, including rules of engagement and contact information
  • MSGene provides a comprehensive, unbiased and regularly updated collection of genetic association studies performed on multiple sclerosis phenotypes
  • Animal Models summarizes the promises and pitfalls of animal models used in MS research
    We added a detailed review of the cuprizone mouse model of MS.

  • Clinical Trials lists sources of information about MS clinical trials

Professional Resources

Forums

Discussions | 22 Oct 2013

Evoked potential test

 
Hi
I'm interested in everything related to Evoked Potential  testing

Recent Comments

News Briefs | 24 Jul 2014
The fact that multiple sclerosis (MS) has a...
New Findings | 15 Jul 2014
More on the PoNS device here: http://...
New Findings | 8 Jul 2014
A tremendous concept, a seminal article that...

MSDF Tweets

NYAS T Cell Meeting

In the News
Read Science Translational Medicine's article about MS Discovery Forum